Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
female (7) 7
index medicus (7) 7
male (7) 7
middle aged (7) 7
peripheral vascular disease (6) 6
aged (5) 5
cardiac & cardiovascular systems (5) 5
cardiovascular (5) 5
blood-pressure (4) 4
cardiology (4) 4
hypertension (4) 4
medicine & public health (4) 4
risk factors (4) 4
disease (3) 3
essential hypertension (3) 3
amiodarone - administration & dosage (2) 2
amiodarone - adverse effects (2) 2
anti-arrhythmia agents - administration & dosage (2) 2
blood pressure - physiology (2) 2
cardiac patients (2) 2
cardiovascular risk (2) 2
cardiovascular-disease (2) 2
care and treatment (2) 2
general practice / family medicine (2) 2
heart failure (2) 2
heart rate - drug effects (2) 2
heart-failure (2) 2
hypertension - complications (2) 2
hypertension - metabolism (2) 2
hypertrophy (2) 2
insulin sensitivity (2) 2
internal medicine (2) 2
left ventricular mass index (2) 2
management (2) 2
metabolic diseases (2) 2
nephrology (2) 2
obesity (2) 2
primary care medicine (2) 2
propafenone - administration & dosage (2) 2
propafenone - adverse effects (2) 2
severity of illness index (2) 2
systemic hypertension (2) 2
therapy (2) 2
24-h urinary sodium (1) 1
abridged index medicus (1) 1
ace (1) 1
active transport, cell nucleus - drug effects (1) 1
active transport, cell nucleus - physiology (1) 1
adhesion (1) 1
adiponectin (1) 1
adipose tissue (1) 1
administration, oral (1) 1
adult (1) 1
adults (1) 1
aged, 80 and over (1) 1
alpha (1) 1
american society (1) 1
amiodarone (1) 1
amiodarone - therapeutic use (1) 1
amlodipine (1) 1
amlodipine - pharmacology (1) 1
amlodipine - therapeutic use (1) 1
anaerobic threshold (1) 1
analysis (1) 1
angiotensin (1) 1
animals (1) 1
anti-arrhythmia agents - adverse effects (1) 1
anti-arrhythmia agents - therapeutic use (1) 1
antihypertensive agents - pharmacology (1) 1
antihypertensive agents - therapeutic use (1) 1
antihypertensive drugs (1) 1
arterial stiffness (1) 1
arterial-hypertension (1) 1
atherosclerosis (1) 1
atherosclerosis-risk (1) 1
atrial (1) 1
atrial fibrillation (1) 1
atrial fibrillation - drug therapy (1) 1
atrial fibrillation - prevention & control (1) 1
autonomic function (1) 1
baroreceptor sensitivity (1) 1
benign (1) 1
benzimidazoles - pharmacology (1) 1
benzimidazoles - therapeutic use (1) 1
benzoates - pharmacology (1) 1
benzoates - therapeutic use (1) 1
beta blockers (1) 1
biochemistry & molecular biology (1) 1
biomarkers - blood (1) 1
blockade (1) 1
body fat (1) 1
body mass index (1) 1
body-composition (1) 1
brain natriuretic peptide (1) 1
brown (1) 1
cancer (1) 1
cardiac-hypertrophy (1) 1
cardiopulmonary exercise testing (1) 1
cardiotonic agents - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage
by Kontaraki, Joanna E., PhD and Marketou, Maria E., MD and Zacharis, Evangelos A., MD and Parthenakis, Fragiskos I., MD, PhD and Vardas, Panos E., MD, PhD, FESC, FACC
Journal of the American Society of Hypertension, ISSN 1933-1711, 2014, Volume 8, Issue 6, pp. 368 - 375
Abstract MicroRNAs (miRs), as essential gene expression regulators, modulate cardiovascular development and disease and thus they are emerging as potential... 
Cardiovascular | essential hypertension | pulse pressure | left ventricular mass index | MicroRNAs | MANAGEMENT | HEART-FAILURE | MECHANISMS | LEFT-VENTRICULAR HYPERTROPHY | BLOOD-PRESSURE | MIR-126 | MIRNA | CARDIAC-HYPERTROPHY | DISEASE | PERIPHERAL VASCULAR DISEASE | CARDIOVASCULAR RISK | Follow-Up Studies | Humans | Middle Aged | Gene Expression Regulation | Male | MicroRNAs - biosynthesis | Hypertension - physiopathology | Hypertension - metabolism | RNA - genetics | Female | Blood Pressure - physiology | MicroRNAs - genetics | Hypertension - genetics | Essential Hypertension | Real-Time Polymerase Chain Reaction
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension
by Kontaraki, Joanna E., PhD and Marketou, Maria E., MD and Parthenakis, Fragiskos I., MD, PhD and Maragkoudakis, Spyros, MD and Zacharis, Evangelos A., MD and Petousis, Stelios, MD and Kochiadakis, George E., MD, PhD and Vardas, Panos E., MD, PhD, FESC, FACC
Journal of the American Society of Hypertension, ISSN 1933-1711, 2015, Volume 9, Issue 10, pp. 802 - 810
Abstract MicroRNAs regulate several aspects of physiological and pathologic cardiac hypertrophy, and they represent promising therapeutic targets in... 
Cardiovascular | miR-499 | miR-208b | Left ventricular mass index | miR-1 | miR-133a | miR-26b | miR-21 | DIFFERENTIAL EXPRESSION | MARKERS | RISK | PREVALENCE | DAMAGE | FAMILY | MASS | PERIPHERAL VASCULAR DISEASE | Leukocytes, Mononuclear - metabolism | Hypertrophy, Left Ventricular - blood | Humans | Hypertrophy, Left Ventricular - etiology | Middle Aged | Male | Gene Expression Profiling | Biomarkers - blood | Reverse Transcriptase Polymerase Chain Reaction | Hypertension - blood | Ultrasonography | Hypertension - complications | Female | Aged | MicroRNAs - blood | Essential Hypertension | Hypertrophy, Left Ventricular - diagnostic imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Differential Effect of Telmisartan and Amlodipine on Monocyte Chemoattractant Protein-1 and Peroxisome Proliferator-Activated Receptor-Gamma Gene Expression in Peripheral Monocytes in Patients With Essential Hypertension
by Marketou, Maria E., MD and Kontaraki, Joanna E., PhD and Tsakountakis, Nikolaos A., MD and Zacharis, Evangelos A., MD and Kochiadakis, George E., MD and Arfanakis, Dimitris A., MD and Parthenakis, Frangiskos, MD and Chlouverakis, Gregory, PhD and Vardas, Panos E., MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2011, Volume 107, Issue 1, pp. 59 - 63
Monocyte chemoattractant protein-1 (MCP-1) and peroxisome proliferator-activated receptor-γ (PPAR-γ) play a significant role in monocyte activation, vascular... 
Cardiovascular | ADHESION | CARDIAC & CARDIOVASCULAR SYSTEMS | MACROPHAGES | ARTERIAL-HYPERTENSION | ATHEROSCLEROSIS | PPAR-GAMMA | ALPHA | TYPE-1 RECEPTOR | BLOCKADE | ANGIOTENSIN | PROGRESSION | Severity of Illness Index | Antihypertensive Agents - pharmacology | Benzoates - therapeutic use | Gene Expression - drug effects | Humans | Middle Aged | Chemokine CCL2 - genetics | Hypertension - drug therapy | Male | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Monocytes - drug effects | Amlodipine - pharmacology | Benzoates - pharmacology | Benzimidazoles - pharmacology | Female | Chemokine CCL2 - drug effects | Benzimidazoles - therapeutic use | PPAR gamma - genetics | Hypertension | Amlodipine | Care and treatment | Gene expression | Angiotensin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A Comparative Study of the Efficacy and Safety of Procainamide Versus Propafenone Versus Amiodarone for the Conversion of Recent-Onset Atrial Fibrillation
by Kochiadakis, George E., MD and Igoumenidis, Nikos E., MD and Hamilos, Michail E., MD and Marketou, Maria E., MD and Chlouverakis, Gregory I., MSc, PhD and Vardas, Panos E., MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 99, Issue 12, pp. 1721 - 1725
The appropriate treatment for the restoration of sinus rhythm in patients with atrial fibrillation (AF) of recent onset is still the subject of controversy. In... 
Cardiovascular | CARDIOVERSION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | THERAPY | DRUGS | SINUS RHYTHM | Single-Blind Method | Injections, Intravenous | Prospective Studies | Atrial Fibrillation - drug therapy | Procainamide - administration & dosage | Humans | Middle Aged | Propafenone - adverse effects | Male | Anti-Arrhythmia Agents - therapeutic use | Anti-Arrhythmia Agents - administration & dosage | Procainamide - therapeutic use | Procainamide - adverse effects | Amiodarone - administration & dosage | Amiodarone - adverse effects | Amiodarone - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Aged, 80 and over | Adult | Female | Propafenone - administration & dosage | Aged | Propafenone - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Association of sodium and potassium intake with ventricular arrhythmic burden in patients with essential hypertension
by Marketou, Maria E., MD, PhD and Zacharis, Evangelos A., MD, PhD and Parthenakis, Fragiskos, MD, PhD and Kochiadakis, George E., MD, PhD and Maragkoudakis, Spyros, MD and Chlouverakis, Gregory, PhD and Vardas, Panos E., MD, PhD, FESC, FACC
Journal of the American Society of Hypertension, ISSN 1933-1711, 2013, Volume 7, Issue 4, pp. 276 - 282
Abstract Background Hypertensive populations suffer from an increased susceptibility to ventricular arrhythmias and sudden cardiac death. A high-salt diet... 
Cardiovascular | urinary sodium | Essential hypertension | urinary potassium | ventricular arrhythmias | ADULTS | PREVENTION | EXCRETION | BLOOD-PRESSURE | SALT | INDIVIDUALS | HYPERTROPHY | DIETARY-SODIUM | DISEASE | PERIPHERAL VASCULAR DISEASE | 24-H URINARY SODIUM | Severity of Illness Index | Humans | Middle Aged | Potassium, Dietary - urine | Sodium, Dietary - urine | Male | Ventricular Premature Complexes - metabolism | Hypertension - metabolism | Ventricular Premature Complexes - diet therapy | Diet, Sodium-Restricted | Ventricular Premature Complexes - diagnosis | Female | Aged | Blood Pressure - physiology | Hypertension - diet therapy | Electrocardiography, Ambulatory
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Amiodarone, Sotalol, or Propafenone in Atrial Fibrillation: Which Is Preferred to Maintain Normal Sinus Rhythm?
by KOCHIADAKIS, GEORGE E and MARKETOU, MARIA E and IGOUMENIDIS, NIKOS E and CHRYSOSTOMAKIS, STAVROS I and MAVRAKIS, HERCULES E and KALEBOUBAS, MICHAIL D and VARDAS, PANOS E
Pacing and Clinical Electrophysiology, ISSN 0147-8389, 11/2000, Volume 23, Issue 11P2, pp. 1883 - 1887
This randomized study compared the efficacy and safety of amiodarone, propafenone and sotalol in the prevention of atrial fibrillation. Methods: The population... 
atrial fibrillation | amiodarone | sinus rhythm maintenance | propafenone | sotalol | MAINTENANCE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | ENGINEERING, BIOMEDICAL | LOW-DOSE AMIODARONE | SUPPRESSION | Recurrence | Administration, Oral | Humans | Middle Aged | Propafenone - adverse effects | Risk Factors | Male | Treatment Outcome | Anti-Arrhythmia Agents - administration & dosage | Amiodarone - administration & dosage | Sotalol - administration & dosage | Amiodarone - adverse effects | Heart Rate - drug effects | Sotalol - adverse effects | Female | Propafenone - administration & dosage | Aged | Atrial Fibrillation - prevention & control | Amiodarone | Propafenone | Atrial fibrillation | Sinus rhythm maintenance | Sotalol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Cell Signaling, Internalization, and Nuclear Localization of the Angiotensin Converting Enzyme in Smooth Muscle and Endothelial Cells
by Héctor A. Lucero and Ekaterina Kintsurashvili and Maria E. Marketou and Haralambos Gavras
Journal of Biological Chemistry, ISSN 0021-9258, 02/2010, Volume 285, Issue 8, pp. 5555 - 5568
The angiotensin converting enzyme (ACE) catalyzes the extracellular formation of angiotensin II, and degradation of bradykinin, thus regulating blood pressure... 
PATHWAYS | DOMAIN | ACE | GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | INHIBITORS | RECEPTORS | PROTEINS | PLASMA-MEMBRANE | EXPRESSION | CANCER | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - metabolism | Transcription, Genetic - drug effects | Active Transport, Cell Nucleus - physiology | Humans | Lysosomes - enzymology | Cell Nucleus - enzymology | Peptidyl-Dipeptidase A - metabolism | Focal Adhesion Kinase 1 - metabolism | Myocytes, Smooth Muscle - cytology | Receptor, Platelet-Derived Growth Factor beta - metabolism | Cell Line | Myocytes, Smooth Muscle - enzymology | Rats | Enzyme Activation - drug effects | Transcription, Genetic - physiology | Animals | Peptidyl-Dipeptidase A - pharmacology | Signal Transduction - drug effects | Endothelial Cells - cytology | Active Transport, Cell Nucleus - drug effects | Signal Transduction - physiology | Endosomes - enzymology | Muscle, Smooth - cytology | Endothelial Cells - enzymology | Enzyme Activation - physiology | Muscle, Smooth - enzymology | Nucleus | Endocytosis | Receptors | Trafficking | Intracellular Trafficking | Cell | Protein | Cell Biology | Sorting
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text B-type natriuretic peptide levels and benign adiposity in obese heart failure patients
by Katsi, Vasiliki and Katsi, Vasiliki and Marketou, Maria and Marketou, Maria and Antonopoulos, Alexios S and Antonopoulos, Alexios S and Vrachatis, Dimitrios and Vrachatis, Dimitrios and Parthenakis, Fragkiskos and Parthenakis, Fragkiskos and Tousoulis, Dimitris and Tousoulis, Dimitris
Heart Failure Reviews, ISSN 1382-4147, 3/2019, Volume 24, Issue 2, pp. 219 - 226
Obesity is a major risk factor for the development of chronic heart failure (CHF) and does not only pose diagnostic challenges, but also has prognostic... 
Heart failure | Obesity | Body mass index | Medicine & Public Health | Cardiology | Natriuretic peptides | NEPRILYSIN INHIBITION | CARDIAC & CARDIOVASCULAR SYSTEMS | ATRIAL | TISSUE | BODY-COMPOSITION | INSULIN SENSITIVITY | NORMAL-WEIGHT | ADIPONECTIN | CARDIOVASCULAR-DISEASE | PLASMA-LEVEL | BROWN | Medical colleges | Cardiac patients | Risk factors | Brain natriuretic peptide | Phenotypes | Adipose tissue | Fat metabolism | Body fat | Benign | Beta blockers | Heart diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Right ventricular dysfunction in arterial hypertension: still terra incognita?
by Marketou, M and Anastasiou, I and Nakou, H and Kochiadakis, G and Patrianakos, A and Fragkiadakis, K and Parthenakis, F
JOURNAL OF HUMAN HYPERTENSION, ISSN 0950-9240, 07/2019, Volume 33, Issue 7, pp. 491 - 498
The effects of systemic hypertension on left ventricular function have been well described, as has been the response of the resulting alterations to... 
GLOBAL LONGITUDINAL STRAIN | HYPERTROPHY | PROGNOSTIC IMPORTANCE | EJECTION FRACTION | HEART-FAILURE | DISEASE | PERIPHERAL VASCULAR DISEASE | SYSTEMIC HYPERTENSION | ECHOCARDIOGRAPHY | EUROPEAN ASSOCIATION | AMERICAN SOCIETY | Hypertension | Complications and side effects | Cardiovascular diseases | Risk factors | Heart | Echocardiography | Magnetic resonance imaging | Clinical trials | Ventricle | Structure-function relationships
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Impact of Arterial Hypertension on the Eye
by Katsi, Vasiliki and Marketou, Maria and Vlachopoulos, Charalambos and Tousoulis, Dimitris and Souretis, George and Papageorgiou, Nikolaos and Stefanadis, Christodoulos and Vardas, Panos and Kallikazaros, Ioannis
Current Hypertension Reports, ISSN 1522-6417, 12/2012, Volume 14, Issue 6, pp. 581 - 590
Systemic hypertension has been linked to a wide range of major eye diseases. High arterial blood pressure (BP) decreases choroidal circulatory flow, increases... 
Hypertension | Nephrology | Eye disease | Hypertensive retinopathy | Medicine & Public Health | Hypertensive choroidopathy | Metabolic Diseases | Cardiovascular risk | General Practice / Family Medicine | Internal Medicine | Primary Care Medicine | Cardiology | RISK-FACTORS | VASCULAR CALIBER | SYSTEMIC HYPERTENSION | VEIN OCCLUSION | RETINAL MICROVASCULAR ABNORMALITIES | BLOOD-PRESSURE | ATHEROSCLEROSIS-RISK | OPEN-ANGLE GLAUCOMA | JAPANESE POPULATION | OCULAR PERFUSION-PRESSURE | PERIPHERAL VASCULAR DISEASE | Hypertension - complications | Hypertensive Retinopathy - etiology | Humans | Risk Factors | Eye Diseases - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Effects of Long-Term Digoxin Therapy on Heart Rate Variability, Baroreceptor Sensitivity, and Exercise Capacity in Patients with Heart Failure
by Vardas, Panos E and Kanoupakis, Emmanuel M and Kochiadakis, George E and Simantirakis, Emmanuel N and Marketou, Maria E and Chlouverakis, Gregory I
Cardiovascular Drugs and Therapy, ISSN 0920-3206, 3/1998, Volume 12, Issue 1, pp. 47 - 55
We evaluated the effects of long-term digoxin therapy on exercise capacity and on physiological parameters reflecting autonomic tone in 23 patients with mild... 
baroreceptor sensitivity | digoxin | Medicine & Public Health | Cardiology | cardiopulmonary exercise testing | heart rate variability | Baroreceptor sensitivity | Cardiopulmonary exercise testing | Digoxin | Heart rate variability | CORONARY-ARTERY DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | POWER SPECTRUM ANALYSIS | AUTONOMIC FUNCTION | PERFORMANCE | ANAEROBIC THRESHOLD | MILD | TRIAL | RESPONSES | END-POINT | PHARMACOLOGY & PHARMACY | LEFT-VENTRICULAR FUNCTION | Cardiotonic Agents - therapeutic use | Heart Rate - drug effects | Exercise Test | Humans | Middle Aged | Female | Male | Aged | Heart Diseases - drug therapy | Digoxin - therapeutic use | Exercise Tolerance - drug effects | Pressoreceptors - drug effects | Heart failure | Physiological aspects | Care and treatment | Cardiac patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol
by Marketou, Maria and Gupta, Yashaswi and Jain, Shashank and Vardas, Panos
Current Hypertension Reports, ISSN 1522-6417, 3/2017, Volume 19, Issue 3, pp. 1 - 10
Blood pressure management in hypertensive patients with metabolic abnormalities is challenging, since many of the antihypertensive drugs adversely affect... 
Hypertension | Nebivolol | Obesity | Nephrology | Medicine & Public Health | Insulin sensitivity | Metabolic Diseases | General Practice / Family Medicine | Internal Medicine | Primary Care Medicine | Lipid metabolism | Cardiology | OXIDATIVE STRESS | ENDOTHELIAL DYSFUNCTION | ANTIHYPERTENSIVE DRUGS | BLOOD-PRESSURE | HYPERTENSIVE PATIENTS | INSULIN-RESISTANCE | ARTERIAL STIFFNESS | NITRIC-OXIDE | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | TYPE-2 DIABETES-MELLITUS | Glucose metabolism | Diabetics | Vasodilators | Analysis | Nitric oxide | Antihypertensive drugs | Insulin resistance | Insulin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.